Tumor protection was also associated with differentiation of CD4+ and CD8+T-subpopulations and NK1.1+activation as measured by granzyme B expression, not detected in the control conditions at day 35 after tumor challenge (Supplementary Figure S3C). This evidence concerns the gene CD8A and neoplasm.